Allurion宣布合作推出Mounjaro®(Tirzepatide)联合疗法并提供折扣价格

美股速递
Feb 03

医疗科技公司ALLURION TECHNOLOGIES(股票代码:ALUR)近日宣布达成一项战略合作,将推出结合Mounjaro®(活性成分:Tirzepatide)的联合治疗方案,并以优惠价格向市场提供。该举措旨在通过整合创新疗法与价格优势,为患者提供更可及的减重管理解决方案。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10